Cadherin subtype switching from E-cadherin to N-cadherin is associated with the epithelial-to-mesenchymal transition (EMT), a process required for invasion and dissemination of carcinoma cells. We found that N-cadherin is expressed in human and mouse pancreatic intraepithelial neoplasia (PanIN), suggesting that N-cadherin may also have a role in early-stage pancreatic cancer. To investigate the role of N-cadherin in mouse PanIN (mPanIN), we simultaneously activated oncogenic K-ras G12D and deleted the N-cadherin (Cdh2) gene in the murine pancreas. Genetic ablation of N-cadherin (N-cad KO) caused hyperproliferation, accelerated mPanIN progression, and early tumor development in K-ras G12D mice. Decreased E-cadherin and redistribution of β-catenin accompanied the loss of N-cadherin in pancreatic ductal epithelial cells (PDEC). Nuclear accumulation of β-catenin and its transcription co-activator Tcf4 led to activation of Wnt/β-catenin target genes. Unexpectedly, loss of N-cadherin in the K-ras G12D model resulted in increased mPanIN progression and tumor incidence. These in vivo results demonstrate for the first time that N-cadherin functions as a growth suppressor in the context of oncogenic K-ras.
INTRODUCTION
Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer death. In the United States, approximately 48 000 patients are diagnosed with pancreatic cancer annually, and nearly an equal number will die from the disease (ACS, 2015) . It is among the most lethal of all cancers, with a 5-year survival rate of only 5%. Activating point mutations in the KRAS oncogene are found in nearly 100% of PDA cases. Although KRAS mutations are important initiating events, it is clear that inactivation of the TP53 and p16/CDKN2A tumor suppressor genes, as well as SMAD pathway genes, is also important for tumor development and progression. 1 A better understanding of the molecular changes driving PDA development is crucial for identifying potential therapeutic targets for this devastating disease.
PDA is thought to evolve through progression of precursor lesions, called pancreatic intraepithelial neoplasias (PanINs). PanINs are classified into four subgroups (1A, 1B, 2 and 3), based upon histological criteria, to describe the progression from hyperplastic to dysplastic ducts. PDA is characterized by genomic instability, and a large number of mutations and chromosomal abnormalities are found in each individual carcinoma. 2, 3 Most human PDAs display mutations in 12 core signaling pathways including homophilic cell adhesion, KRAS and Wnt signaling pathways, 3 but whether these pathways work in concert to enhance disease progression is unknown.
Classical cadherins are a family of cell surface glycoproteins that mediate calcium-dependent cell-cell adhesion primarily in a homophilic manner. Their adhesive function requires interaction with the actin cytoskeleton through catenins. It has been shown that cadherins have a role in late-stage tumorigenesis. 4 Specifically, cadherin subtype switching-from E-cadherin to N-cadherin -occurs during neoplastic cell invasion and metastasis and is associated with the epithelial-to-mesenchymal transition (EMT). 5, 6 Cadherin switching usually refers to a change in expression from E-cadherin to N-cadherin, but also includes situations in which E-cadherin levels do not change significantly but cells turn on N-cadherin expression. N-cadherin is not required for the EMT process itself, but it regulates the cell's behavior following EMT including the cell's migratory ability. 7 This hypothesis is supported by genetic studies demonstrating that neoplastic cell behavior is sensitive to changes in N-cadherin expression levels. [8] [9] [10] A role for N-cadherin in the early stage of cancer development has not been studied. However, one study suggested that changes in E-cadherin might have a role in human PanIN development. 11 E-cadherin was reduced at the membrane and increased in the cytoplasm in PanIN compared with normal ducts. 11 Notably, β-catenin, a downstream effector of the Wnt signaling pathway, was found in the cytoplasm and nucleus of high-grade PanIN lesions. Furthermore, K-ras G12D -induced mPanINs express Tcf4 in the nucleus and exhibit activation of the β-catenin/Tcf4-responsive LacZ-reporter consistent with a role for Wnt signaling in mPanIN development. 12 To our knowledge, N-cadherin protein expression has not been examined in PanIN, although its expression has been reported in primary and metastatic PDA. 13 Canonical Wnt signaling was shown recently to be required for mPanIN formation. 14 Three complementary approaches were used to inhibit Wnt/β-catenin signaling in the K-ras G12D mouse model. First, genetic mosaicism of β-catenin in the K-ras G12D pancreas demonstrated that β-catenin-null cells did not contribute to mPanIN lesions. Second, induction of the secreted Wnt inhibitor Dkk1 in the K-ras G12D pancreas inhibited mPanIN development and progression. Third, treatment of K-ras G12D mice with a monoclonal antibody that binds to multiple Frizzled receptors and blocks their activity resulted in fewer mPanINs compared with non-treated K-ras G12D animals. Taken together, these data demonstrate a need for canonical Wnt signaling in K-ras G12Dinduced mPanIN development.
Herein we report that N-cadherin is induced in human and murine PanINs, and that deletion of N-cadherin (Cdh2) gene in ductal cells leads to activation of Wnt/β-catenin target genes and accelerated mPanIN formation in the K-ras G12D mouse model. These in vivo results demonstrate for the first time that N-cadherin functions as a growth suppressor in the context of oncogenic K-ras.
RESULTS AND DISCUSSION
N-cadherin is expressed in PanIN lesions N-cadherin expression is associated primarily with poorly differentiated tumors, but no information is available concerning N-cadherin expression in PanIN, precursor lesions to PDA. Therefore, we examined N-cadherin expression in both human and murine PanIN specimens. In human pancreas, E-cadherin was located primarily at the lateral borders between the pancreatic ductal epithelial cells (PDEC) in normal tissue, whereas N-cadherin was never observed in normal ducts (Figures 1a and b ). By contrast, in human PanIN lesions N-cadherin was found to be expressed in ductal cells where it localized to regions of cell-cell contact together with E-cadherin ( Figures 1c and d ; Supplementary Figure 1 ). N-cadherin staining was heterogeneous and often less intense compared with E-cadherin in PanINs. The human data were confirmed in LSL-K-ras G12D ; Pdx1/Cre mice (referred to as KC mice) that develop mPanIN lesions similar to humans. 15 Co-expression of N-cadherin and E-cadherin was observed in mPanIN, along with N-cadherin-positive ductal cells with weak or little E-cadherin expression (Figures 1e and f). Next, we took advantage of a N-cadherin reporter mouse line (Ncad lacZ/+ ) where the lacZ gene is under the transcriptional regulation of the endogenous N-cadherin promoter. 16 The Ncad lacZ/+ reporter allele was introduced into the KC and KPC 17 (that is, LSL-K-ras G12D ; LSL-Trp53 R172H ; Pdx1/Cre) mouse models. In addition to islets of Langerhans and nerve bundles where N-cadherin is expressed normally, β-galactosidase activity was observed in PDA of the KPC mice confirming the utility of the Ncad lacZ/+ reporter (Supplementary Figure 2 ). Importantly, the Ncad lacZ/+ reporter was active in mPanIN lesions of the KC mice, thus confirming expression of N-cadherin in these early precursor lesions (Figure 1h ). Collectively, these in vivo data demonstrate that ectopic N-cadherin expression occurs initially at the PanIN stage of the disease before EMT.
Loss of N-cadherin in the context of oncogenic K-ras leads to increased mPanIN incidence and progression
To determine the consequences of interfering with N-cadherin function during mPanIN development, the N-cadherin floxed allele 18 was introduced into the KC model to generate LSL-Kras G12D ; N-cad fl/fl ; Pdx1/Cre mice referred to as Ncad knockout (KO). KC mice not containing the N-cadherin floxed alleles are referred to as Ncad wild type (WT). LSL-K-ras G12D ; N-cad fl/fl mice lacking the Cre transgene served as negative controls. Pancreas development and morphology are normal in N-cad fl/fl ; Pdx1/Cre mice lacking the K-ras mutation. 19 Surprisingly, the Ncad KO pancreata were significantly larger compared with Ncad WT (Figures 2a and b ). In comparison with Ncad WT, the Ncad KO exhibited extensive mPanINs accompanied by periductal desmoplasia ( Figure 2c ). Significant collagen deposition was associated with the desmoplastic reaction in the Ncad KO as depicted by Masson Trichrome stain (Figure 2d ). Alcian blue staining identified abundant mucin in the Ncad KO mPanIN lesions (Figure 2e ). The changes in Ncad KO mice were not seen in Ncad heterozygous mice (LSL-K-ras G12D ; N-cad lacZ/+ ; Pdx1/Cre) (data not shown). The proliferative index of mPanINs was assessed by PCNA immunohistochemistry. There was a two-fold increase in PCNA-positive ductal cells in N-cad KO compared with N-cad WT mPanIN lesions at comparative mPanIN grades (Figures 2f and g) . To determine whether loss of N-cadherin affected K-ras activity, we examined levels of activated, or GTP-bound, Ras. There was no change in Ras-GTP levels between Ncad KO and WT pancreata (Supplementary Figure 3 ). Together, these data indicate that loss of N-cadherin caused an increase in ductal cell proliferation leading to excessive mPanIN development in the context of K-ras G12D .
Similar to human disease, the KC mice recapitulate the progression from mPanIN-1 to PanIN-3 eventually developing PDA after 1 year of age. 15 We examined sections from the pancreata of each transgenic model to score the presence of different grades of mPanIN or PDA, which were defined by the consensus criteria of the pancreatic mouse modeling community. 20 Histological examination showed evidence of accelerated mPanIN development in Ncad KO compared with Ncad WT KC mice. Between 8 and 12 months of age, the majority of mPanIN lesions in Ncad WT mice were classified as mPanIN-2 whereas Ncad KO displayed less mPanIN-2 and more advanced mPanIN-3 lesions as well as invasive carcinoma (Ncad KO, 6/26 vs Ncad WT 1/18, P o0.05) (Figure 3a) . PET imaging detected a strong 18 F-FDG signal in the abdominal region of an 8-month-old Ncad KO (Figure 3b ). The pancreas was removed and a solid mass identified (Figure 3c ), and histological examination confirmed the carcinoma pathology (Figure 3d ). Taken together, we conclude that mPanIN progression and tumorigenesis were accelerated in Ncad KO compared with Ncad WT KC mice.
E-cadherin and β-catenin expression in N-cadherin KO mPanIN lesions E-cadherin was expressed strongly at the lateral borders of the Ncad WT ductal epithelial cells ( Supplementary Figure 4b) . In comparison, E-cadherin expression was weaker in the Ncad KO ducts ( Supplementary Figure 4c ). Western analysis was performed on total pancreata lysates ( Supplementary Figure 4d ). Quantification of E-cadherin relative to the ductal marker cytokeratin 19 Figure 4e) .
Changes in E-cadherin levels can modulate β-catenin activity and growth of neoplastic cells. 21 Therefore, we examined β-catenin expression in pancreata from 6-month-old Ncad KO and WT KC mice. β-Catenin was increased in the cytoplasm and nuclei of the Ncad KO compared with WT ductal cells (Figure 4a ).
Moreover, in adjacent Ncad KO sections we observed an increase in nuclear localization of the β-catenin binding partner, Tcf4 (Figures 4b and c ). Next, we examined the expression of representative β-catenin/Tcf4 target genes in these pancreata from 6-month-old mice. Loss of N-cadherin was associated with increased expression of axin2 and MMP-7 transcripts in Ncad KO pancreata compared with Ncad WT (Figure 4d ). To further examine the cellular distribution of β-catenin, primary PDEC lines were derived from Ncad KO and WT pancreata as previously described. 22 As predicted from the genotypes, N-cadherin was absent from the N-cad KO PDEC lines (Figure 4e ). Cellular fractionation demonstrated that β-catenin was increased in the nuclear fraction of the Ncad KO PDECs (Figure 4f ). Moreover, expression of cyclin D1, a Wnt/β-catenin target, was increased in the Ncad KO PDECs (Figure 4e ). Taken together, these data suggest that an overall decrease in cadherin expression leads to increased nuclear β-catenin and expression of Wnt/β-catenin target genes, thus contributing to the acceleration of mPanIN development in the Ncad KO KC mice.
Perspective
Contact inhibition of cell proliferation is often invoked in the context of epithelial cells where E-cadherin-mediated adhesion restrains cell growth and division. 23 By contrast, N-cadherin expression is generally associated with EMT and the acquisition of mesenchymal morphology and migratory capabilities. 6 In this study, we found N-cadherin expression at an earlier stage of pancreatic cancer than previously appreciated. Subpopulations of ductal cells in human and murine PanIN lesions were positive for N-cadherin. Surprisingly, genetic ablation of N-cadherin caused ductal cell hyperproliferation and accelerated mPanIN progression in the K-ras G12D mice. This result indicates that N-cadherin regulates the proliferative potential of a unique subset of ductal cells in mPanIN lesions.
It has been proposed that oncogenic K-ras regulates N-cadherin expression in pancreatic cancer; however, its relevance to disease progression is poorly understood. In PDEC grown in culture, activated K-ras was shown to induce N-cadherin expression. 24, 25 In comparison with these in vitro results, here we show that only a subset of ductal cells express N-cadherin in K-ras G12D -induced mPanIN lesions. However, when PDEC isolated from N-cad WT K-ras G12D mice were grown in vitro, N-cadherin induction was observed in all the cells. Interestingly, N-cadherin expression in pancreatic cancer cell lines depends on signals from the extracellular matrix. Cells grown on collagen I activate N-cadherin whereas fibronectin or laminin substrates had no effect on N-cadherin expression. 9 The difference between these in vitro and in vivo findings suggests that the PanIN microenvironment, for example, basement membrane, may regulate N-cadherin activation in vivo. In the future, it will be of interest to examine N-cadherin expression in PanIN lesions with respect to changes in basement membrane integrity.
Studies indicate that the ability of N-cadherin to regulate cell proliferation depends on the cellular context and the health of the tissue. N-cadherin-mediated adhesion was shown to promote cellcycle arrest of CHO cells 26 and C2C12 myoblasts 27, 28 in culture. Moreover, we reported recently that interfering with α-catenins, which link N-cadherin to the actin cytoskeleton, results in aberrant N-cadherin expression and hyperproliferation of cardiomyocytes. 29 By contrast, in another study it was shown by use of N-cadherin conditional KO mice that N-cadherin is a positive regulator of smooth muscle cell proliferation following vascular injury. 30 Moreover, we previously reported that reduced N-cadherin levels in the context of both K-ras G12D and p53 R172H mutations (that is, KPC mice) led to a decrease in proliferation of pancreatic cancer cells consistent with a growth-promoting role for N-cadherin in later stage cancer. 10 The different effects of N-cadherin on PDEC growth in the KPC 10 and KC (this study) mouse models depend on N-cadherin gene dosage (summarized in Supplementary Table I ). Taken together, these data show that N-cadherin can either inhibit or promote cell proliferation depending on the cellular context and disease state.
It is well established that activation of Wnt signaling has a critical role in mPanIN development. 14 In the present study, we demonstrate an increase in nuclear localization of β-catenin and Tcf4, and in expression of target genes in the N-cad KO KC mice. These data support the idea that decreased cadherin expression in N-cad KO KC mice alters the cellular distribution of β-catenin (membrane vs cytoplasmic) and facilitates its accumulation in the nucleus where it activates genes involved in mPanIN formation. Additional signaling pathways including the Hippo pathway may work in concert with N-cadherin-mediated adhesion to regulate proliferation in the K-ras G12D mice. 31 Interestingly, it was shown recently that E-cadherin mediates contact inhibition of proliferation in mammary epithelial cells via Hippo signaling pathway components and the regulation of the subcellular localization of Yes-associated protein (Yap). 32 Yap is a transcriptional co-activator that interacts with members of the TEAD transcription factor family to regulate genes involved in cell proliferation and survival. Importantly, it was shown that Yap is required in β-catenindependent cancers. 33 Yap and the transcription factor Tbx5 were found to form a complex with β-catenin. Whether loss of N-cadherin modulates Yap nuclear translocation in mPanIN lesions is under investigation.
Previous studies indicated that N-cadherin was capable of promoting pancreatic tumor cell growth. 9, 10 By contrast, here we report for the first time that N-cadherin functions as a growth suppressor in the context of K-ras-induced mPanIN development. Loss of N-cadherin causes activation of the Wnt/β-catenin signaling pathway and ductal cell hyperproliferation in K-ras G12D mice. Our unexpected results provide new insight into N-cadherin function in early pancreatic cancer.
